Therapeutic strategies for acute intermittent porphyria

Acute intermittent porphyria (AIP) is an autosomal dominant disease caused by mutations in porphobilinogen deaminase (PBGD), the third enzyme of the heme synthesis pathway. Symptoms of AIP usually manifest as intermittent acute attacks with occasional neuropsychiatric crises. The management of AIP i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Intractable Rare Dis Res
Egile Nagusiak: Zhao, Lanlan, Wang, Xinyang, Zhang, Xiaoning, Liu, Xiantao, Ma, Ningzhen, Zhang, Yiran, Zhang, Songyun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: International Research and Cooperation Association for Bio & Socio-Sciences Advancement 2020
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7586882/
https://ncbi.nlm.nih.gov/pubmed/33139979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2020.03089
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak